In 2016, Philip Morris International (PMI) announced our vision of a smoke-free future and our ambition to accelerate the end of smoking. To achieve this, we are working to replace cigarettes with less harmful tobacco and nicotine products for the benefit of adults who would otherwise continue to smoke.
Explore our product assessment program, the results of our evaluations, and the publications in which those results are published.
Our Open Science event series is an important platform for sharing our scientific research and engaging with the scientists, medical professionals, public health experts, regulators, journalists, and members of the public on topics such as tobacco harm reduction, eliminating combustion, developing smoke-free products, and the potential health impact of our products. Since June 2020, we have hosted more than 10 sessions, both virtually and in person, creating an open dialogue with the global scientific and wider community. Stay informed about our events by subscribing to our Open Science updates.
Smoke-free products is the term Philip Morris International (PMI) uses to refer to products that provide nicotine without burning tobacco. These products deliver nicotine and far lower quantities of harmful and potentially harmful constituents compared with cigarette smoke. Because no combustion takes place, smoke-free products have the potential to present less risk of harm to adult smokers who switch to them versus continuing to smoke.
Find useful information about the current state of PMI Science research and development
Whether you have a question, a comment, or an idea, send us a message. Open dialogue is something we are passionate about, and we would like to know your views.